Martin Shkreli
Latest Stories
martin_shkreli_trial_54914.jpg
FILE - In this Monday, June 19, 2017, file photo, former Turing Pharmaceuticals CEO Martin Shkreli, second from right, arrives at Brooklyn federal court with members of his legal team, in New York, for a pretrial conference in his securities fraud trial. Shkreli's trial begins Monday, June 26, 2017. (AP Photo/Mark Lennihan, File)
martin_shkreli_trial_28958.jpg
Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)
aptopix_martin_shkreli_trial_67039.jpg
Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman, in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)
martin_shkreli_trial_06485.jpg
Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)
martin_shkreli_trial_44105.jpg
In this Monday, June 19, 2017, file photo, former Turing Pharmaceuticals CEO Martin Shkreli arrives at Brooklyn federal court with members of his legal team, in New York, for a pretrial conference in his securities fraud trial. Shkreli's trial begins Monday, June 26. (AP Photo/Mark Lennihan, File)
martin_shkreli_twitter_34292.jpg
FILE - In this Feb. 4, 2016 file photo, Pharmaceutical chief Martin Shkreli smiles on Capitol Hill in Washington during the House Committee on Oversight and Reform Committee hearing on his former company's decision to raise the price of a lifesaving medicine. Twitter cited harassment when asked Jan. 9, 2017, why Shkreli's account had been suspended from the platform. (AP Photo/Susan Walsh, File)
drug_price_hikes_shkreli.jpeg
Pharmaceutical chief Martin Shkreli smiles on Capitol Hill in Washington, Thursday, Feb. 4, 2016, during the House Committee on Oversight and Reform Committee hearing on his former company's decision to raise the price of a lifesaving medicine. Shkreli refused to testify before U.S. lawmakers who excoriated him over severe hikes for a drug sold by a company that he acquired. (AP Photo/Susan Walsh) ** FILE **
kalobios-shkreli_fired.jpeg
In this Dec. 17, 2015 file photo, Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli resigned as the head of Turing Pharmaceuticals, one of the companies he runs, and another, KaloBios Pharmaceuticals, said Monday, Dec. 21, in a printed statement that it terminated Shkreli last week.. (AP Photo/Craig Ruttle, File)
Shkreli Resignation.JPEG-0fc0d.jpg
FILE - In this Dec. 17, 2015 file photo, Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York after being taken into custody following a securities probe. Shkreli has resigned as the head of one of the companies he now runs, Turing Pharmaceuticals, on Friday, Dec. 18, 2015.(AP Photo/Craig Ruttle)
